The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines
Open accessAbstract
BACKGROUND: Coronavirus disease 2019 (COVID-19) is pandemic and has caused illness to many people worldwide. This review aimed to summarize and analyze the herbal formulae provided by the guidelines for their pattern identifications (PIs) and compositions of herbs to treat patients with COVID-19. METHODS: We searched 7 data sources for eligible traditional medicine guidelines up to March 6, 2020 and found a total of 28 traditional medicine guidelines that provide treatment measures for COVID-19. RESULTS: Of the 28 guidelines, there were 26 government-issued Chinese guidelines and 2 Korean guidelines. After standardizing the terminology of the PIs and herbal formulae, there were 8 PIs and 23 herbal formulae for the mild stage, 11 PIs and 31 herbal formulae for the moderate stage, 8 PIs and 21 herbal formulae for the severe stage, and 6 PIs and 23 herbal formulae for the recovery stage in the Chinese guidelines. In the Korean guidelines, there were 4 PIs and 15 herbal formulae for the mild stage, 3 PIs and 3 herbal formulae for the severe stage, and 2 PIs and 2 herbal formulae for the recovery stage. In the frequency analysis of herbs, Glycyrrhizae Radix et Rhizoma was found to be the herb with the highest frequency of usage in the Chinese guidelines. CONCLUSION: This review can be used as guidance for the traditional medicine treatment of COVID-19. Clinical evidence is needed in the future to evaluate the efficacy of traditional medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luo, H., Tang, Q.-L., Shang, Y.-X., Liang, S.-B., Yang, M., Robinson, N., & Liu, J.-P. (2020) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-020-3192-6 · Cited by 613
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
Chen, F., Chan, K. H., Jiang, Y., Kao, R. Y. T., Lu, H. T., Fan, K. W., Cheng, V. C. C., Tsui, W. H. W., Hung, I. F. N., & Lee, T. S. W. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.03.003 · Cited by 534
Traditional Chinese herbal medicine as a source of molecules with antiviral activity
Li, T., & Peng, T. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2012.10.006 · Cited by 223
Guo, S., Jiang, K., Wu, H., Yang, C., Yang, Y., Yang, J., Zhao, G., & Deng, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00982 · Cited by 97
Hu, X., Fu, Y., Lu, X., Zhang, Z., Zhang, W., Cao, Y., & Zhang, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00644 · Cited by 41
Cited by
The Food Systems in the Era of the Coronavirus (COVID-19) Pandemic Crisis
Galanakis, C. M. (2020) · Foods · doi:10.3390/foods9040523 · Cited by 926
An Update on Current Therapeutic Drugs Treating COVID-19
Wu, R., Wang, L., Kuo, H.-C. D., Shannar, A., Peter, R., Chou, P. J., Li, S., Hudlikar, R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 599
Huang, K., Zhang, P., Zhang, Z., Youn, J. Y., Wang, C., Zhang, H., & Cai, H. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107843 · Cited by 552
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
Heidary, F., & Gharebaghi, R. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0336-z · Cited by 435
COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?
Silveira, D., Prieto-Garcia, J. M., Boylan, F., Estrada, O., Fonseca-Bazzo, Y. M., Jamal, C. M., Magalhães, P. O., Pereira, E. O., Tomczyk, M., & Heinrich, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.581840 · Cited by 279
Metadata
- Authors
- Ang, L., Lee, H. W., Choi, J. Y., Zhang, J., & Lee, M. S.
- Venue
- Integrative Medicine Research
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 9
- Issue
- 2
- Pages
- 100407
- ISSN
- 2213-4220 (ISSN-L)
- OpenAlex
- W3013610324
- Cited by
- 258
- References
- 5
- FWCI
- 53.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. https://app.cochat.ai/papers/10.1016/j.imr.2020.100407
- The paper
- Ang, L., Lee, H. W., Choi, J. Y., Zhang, J., & Lee, M. S. (2020). Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integrative Medicine Research. https://doi.org/10.1016/j.imr.2020.100407
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.